SF Medical ApS: Financial statements 2017
CVR: 36964901
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
SF Medical ApS (CVR 36964901) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 72,618 and a net result of DKK -33,172 compared with DKK -184,667 the year before. Equity in the 2017 report amounted to DKK -167,839.
- Gross Profit
- DKK 72,618
- Profit/Loss
- DKK -33,172
- Equity
- DKK -167,839
- Total Assets
- DKK 434,318
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 73 t. | -33 t. | -168 t. | - |
| 2016 | - | -156 t. | -185 t. | -135 t. | - |
Official annual report
Keep an eye on SF Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 29, 2017, Louise Margrethe Deichmann is registered as adm. dir. of SF Medical ApS.
As of June 28, 2017, Jan Ove Myklebust has stepped down as adm. dir. of SF Medical ApS.
As of March 1, 2017, Michael Edward Newcomb Burgess has left the board of directors of SF Medical ApS.
As of March 1, 2017, Flemming Ammentorp Østergaard has left the board of directors of SF Medical ApS.
As of March 1, 2017, Jan Ove Myklebust has left the board of directors of SF Medical ApS.
As of March 1, 2017, Jan Ove Myklebust is registered as adm. dir. of SF Medical ApS.
As of March 1, 2017, Michael Edward Newcomb Burgess has stepped down as adm. dir. of SF Medical ApS.
About SF Medical ApS
SF Medical ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jan Ove Myklebust. The company is owned by MYKLEBUST HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -60,396 and a net result of DKK 3,682 compared with DKK -234,262 the year before. Equity in the 2025 report amounted to DKK 159,745.